XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Revenues $ 3,145.0 $ 3,162.1
Expenses:    
Research and development 1,248.4 1,101.2
Acquired in-process research and development 7.1 56.1
Selling, general, and administrative 689.0 601.1
Other operating expense (income), net 15.3 (0.5)
Total Expenses 2,393.6 2,215.4
Income from operations 751.4 946.7
Other income (expense):    
Other (expense) income, net (34.6) (70.7)
Interest expense (16.1) (18.0)
Total other income (expense) (50.7) (88.7)
Income before income taxes 700.7 858.0
Income tax (benefit) expense (21.3) 40.2
Net income $ 722.0 $ 817.8
Net income per share - basic (in dollars per share) $ 6.70 $ 7.64
Net income per share - diluted (in dollars per share) $ 6.27 $ 7.17
Weighted average shares outstanding - basic (in shares) 107.8 107.1
Weighted average shares outstanding - diluted (in shares) 115.1 114.0
Statements of Comprehensive Income    
Net income $ 722.0 $ 817.8
Other comprehensive income (loss), net of tax:    
Unrealized gain on debt securities 3.5 57.2
Gain on foreign currency translation 0.2 0.0
Comprehensive income 725.7 875.0
Net product sales    
Revenues:    
Revenues 1,761.3 1,668.0
Expenses:    
Cost of goods, collaboration and contract manufacturing 240.4 208.4
Collaboration revenue    
Revenues:    
Revenues 1,266.8 1,378.1
Other revenue    
Revenues:    
Revenues 116.9 116.0
Cost of collaboration and contract manufacturing    
Expenses:    
Cost of goods, collaboration and contract manufacturing $ 193.4 $ 249.1